Has Emily Sisa received payments from drug or device companies?

Yes. Drug and device makers reported $1,224 in general payments to Emily Sisa across 67 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Emily Sisa did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Emily Sisa come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Emily Sisa

Psychiatric/Mental Health · Lone Tree, CONPI 1275102873

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 27.1% of the total. Reporting peaked in 2021 at $471 and has fallen 79.4% since, to $97 in 2025.

$1,224in general payments, 2019–2025

Across 67 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$332
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$159
Novo Nordisk$141
Lilly USA, LLC$100
Takeda Pharmaceuticals U.S.A., Inc.$81
Otsuka America Pharmaceutical, Inc.$58
plus $354 from 15 others

What the payments were for

Food & beverage$1,17796%
Education$474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	18	$332
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$159
Novo Nordisk	9	$141
Lilly USA, LLC	7	$100
Takeda Pharmaceuticals U.S.A., Inc.	4	$81
Otsuka America Pharmaceutical, Inc.	3	$58
AstraZeneca	3	$46
Hologic Sales And Service, LLC	2	$40
Biohaven Pharmaceuticals, Inc.	2	$35
Biohaven Pharmaceutical Holding Company Ltd.	2	$28
Alkermes, Inc.	1	$27
Neurocrine Biosciences, Inc.	1	$26
Sanofi Pasteur Inc.	1	$21
Sunovion Pharmaceuticals Inc.	1	$20
Axsome Therapeutics, Inc.	1	$19
Amarin Pharma, Inc.	1	$17
Kowa Pharmaceuticals America, Inc.	1	$17
Lucid Diagnostics Inc.	1	$16
Optinose US, Inc.	1	$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$13
Bayer	1	$13

How this compares

$1,224 in reported general payments places this provider in the 75th percentile of 873 psychiatric/mental health providers in Colorado.

See all psychiatric/mental health providers in Colorado →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluoxetine Hcl	17	$87

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Lone Tree

Chelsie MonroeLittleton$998K
Audrey StrockDenver$499K
Pinkie FittsAurora$444K
Mark JankelowColorado Springs$287K
Cristi BundukamaraColorado Springs$230K
Deborah YorkDenver$158K
Shelley AbadiLakewood$19K
James AndersonWheat Ridge$18K
Eliza MarroniGrand Junction$17K
Sylvia KingPueblo West$17K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →